Prognostic value of plasma biomarkers for informing clinical trial design in mild-to-moderate Alzheimer's disease.
Saved in:
| Title: | Prognostic value of plasma biomarkers for informing clinical trial design in mild-to-moderate Alzheimer's disease. |
|---|---|
| Authors: | Qiu, Yuqi1,2 (AUTHOR), Jacobs, Diane M.3,4 (AUTHOR) djacobs@ucsd.edu, Messer, Karen2,4 (AUTHOR), Salmon, David P.3,4 (AUTHOR), Wellington, Cheryl L.5,6 (AUTHOR), Stukas, Sophie5 (AUTHOR), Revta, Carolyn4 (AUTHOR), Brewer, James B.3,4 (AUTHOR), Léger, Gabriel C.3,4 (AUTHOR), Askew, Brianna4,7 (AUTHOR), Donahue, Lia7 (AUTHOR), Kaplita, Stephen7 (AUTHOR), Coric, Vladimir7 (AUTHOR), Qureshi, Irfan A.7 (AUTHOR), Feldman, Howard H.3,4 (AUTHOR), Obisesan, Thomas (AUTHOR), Smith, Amanda (AUTHOR), Heidebrink, Judith (AUTHOR), Mintzer, Jacobo (AUTHOR), Ala, Thomas (AUTHOR) |
| Source: | Alzheimer's Research & Therapy. 5/2/2025, Vol. 17 Issue 1, p1-14. 14p. |
| Database: | Academic Search Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
Be the first to leave a comment!
